Pediatric Medicines Market
Global Pediatric Medicines Market Size, Share & Trend Analysis Report by Drug Type (Allergy and Respiratory Drugs, Cancer Therapies, Cardiovascular Drugs, and Gastrointestinal Drugs), By the Route of Administration (Oral, Topical, and Parenteral), Forecast (2022-2028) Update Available - Forecast 2024-2030
The global pediatric medicines market is anticipated to grow at a significant CAGR of around 5% during the forecast. Pediatric medicines are used for the treatment of several diseases in the child. The increase in several disorders including asthma, anorexia cancer in children, growth deficiency, birth defects, juvenile diabetes, and others is a major factor for increasing the demand for pediatric medicines. Furthermore, there are several acts such as the Best Pharmaceuticals for Children Act (BPCA) and the Pediatric Research Equity Act (PREA), thereafter propelling the key players of the market to increase the investment in research and development activities of pediatric medicines. For instance, in a report published by Omnia Health in May 2020, there are some major devices and developments in child health technology including gene therapy, high flow oxygen therapy, smart pill, neonatal body monitors, and others. The report also concludes that there are more opportunities for the development of pediatric medicines than adults.
Impact of COVID-19 on Global Pediatric Medicines Market
COVID-19 has impacted the global economy due to a slowdown in the manufacturing of various industries. Healthcare came under the essential services so the manufacturing of pediatric medicines was continuous throughout the pandemic. The distribution and demand of pediatric medicines were regular as pediatric patients are increasing throughout the pandemic.
Segmental Outlook
The global pediatric medicines market is segmented based on drug type and the route of administration. Based on drug type, the market is sub-segmented into allergy and respiratory drugs, cancer therapy drugs, cardiovascular drugs, and gastrointestinal drugs. Based on the foot of administration, the market is sub-segmented into oral, topical, and parenteral. Among these, allergy and respiratory drug type are expected to hold a prominent share in the global pediatric medicines market due to the increasing number of infants suffering from allergic respiratory diseases.
Global Pediatric Medicines Market by the Route of Administration, 2021(%)
The Oral Segment is Anticipated to Hold a Major Share in the Global Pediatric Medicines market.
The oral pediatric medicines segment is expected to hold the major share in the global pediatric medicines market during the forecast year due to the oral route of the administration having several benefits. The benefits include safety, convenience, and cost-efficiency are the key factors for the growth of the oral segment in pediatric medicines. However, the medicines are not directly applied to the target site in the oral segment and moved through the digestive tract may hinder the adoption rate of the oral segment in the global pediatric medicines market.
Regional Outlooks
The global pediatric medicines market is further segmented based on geography including North America (the US, and Canada), Europe (Italy, Spain, Germany, France, and Others), Asia-Pacific (India, China, Japan, South Korea, and Others), and the Rest of the World (the Middle East & Africa, and Latin America). The Asia Pacific region is expected to hold the major share in the global pediatric medicines market due to major economies such as China, Japan, and India contributing to the regional growth. The rising awareness and growing access to advanced pediatric drugs is expected to be the reason for the growth in the region. In addition, developing healthcare infrastructure in the region is expected to drive market growth.
Global Pediatric Medicines Market Growth by Region, 2022-2028
The North American Region is Expected to Grow at a Significant CAGR among the Global Pediatric Medicines Market During Forecast Year.
The North American regional pediatric medicines market is anticipated to grow at a significant CAGR during the forecast year due to the presence of a large pediatric population in the region along with wait the growing availability of options to treat pediatric diseases. High per capita healthcare expenditure and well-established healthcare infrastructure are some other factors for the growth of the pediatric medicines market in North America. Moreover, easy access to advanced pediatric medicines and improvement in research and development activities by the players present in the region, increasing demands for such medicines is further expected to drive the growth of the market in North America.
Market Players Outlook
The major companies serving the global Pediatric Medicines market include Abbvie Inc., Johnson & Johnson, Bayer AG, GlaxoSmithKline plc, F. Hoffmann-La Roche Ltd., and many others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers & acquisitions, collaborations, fundings, and new product launches. For instance, in December 2019, the primary children’s center is launched by Intermountain Primary Children’s Hospital, University of Utah Health, and Intermountain Precision Genomics for personalized medicine for pediatric patients. The center will bring personalized medicine to pediatric patients using head marks technologies by understanding their unique genetic makeup.
The Report Covers
- Market value data analysis of 2021 and forecast to 2028.
- Annualized market revenues ($ million) for each market segment.
- Country-wise analysis of major geographical regions.
- Key companies operating in the global pediatric medicines market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
- Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
- Analysis of market-entry and market expansion strategies.
- Competitive strategies by identifying ‘who-stands-where’ in the market
1. Report Summary
• Current Industry Analysis and Growth Potential Outlook
• Impact of COVID-19 on The Global Pediatric Medicines Market
• Recovery Scenario of Global Pediatric Medicines Market
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
1.2.2. BY Region
2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
3. Competitive Landscape
3.1. AbbVie Inc.
3.1.1. Overview
3.1.2. Financial Analysis
3.1.3. SWOT Analysis
3.1.4. Recent Developments
3.2. Bayer AG
3.2.1. Overview
3.2.2. Financial Analysis
3.2.3. SWOT Analysis
3.2.4. Recent Developments
3.3. F. Hoffmann-La Roche Ltd.
3.3.1. Overview
3.3.2. Financial Analysis
3.3.3. SWOT Analysis
3.3.4. Recent Developments
3.4. GlaxoSmithKline plc.
3.4.1. Overview
3.4.2. Financial Analysis
3.4.3. SWOT Analysis
3.4.4. Recent Developments
3.5. Johnson & Johnson Pvt. Ltd.
3.5.1. Overview
3.5.2. Financial Analysis
3.5.3. SWOT Analysis
3.5.4. Recent Developments
3.6. Key Strategy Analysis
3.7. Impact of Covid-19 on Key Players
4. Market Segmentation
4.1. Global Pediatric Medicines Market by Drug Type
4.1.1. Allergy and Respiratory Drugs
4.1.2. Cancer Therapies
4.1.3. Cardiovascular Drugs
4.1.4. Gastrointestinal Drugs
4.2. Global Pediatric Medicines Market by Route of Administration
4.2.1. Oral
4.2.2. Topical
4.2.3. Parenteral
5. Regional Analysis
5.1. North America
5.1.1. The US
5.1.2. Canada
5.2. Europe
5.2.1. UK
5.2.2. Germany
5.2.3. Italy
5.2.4. Spain
5.2.5. France
5.2.6. Rest of Europe
5.3. Asia-Pacific
5.3.1. China
5.3.2. India
5.3.3. Japan
5.3.4. South Korea
5.3.5. Rest of Asia-Pacific
5.4. Rest of the World
6. Company Profiles
6.1. Abbott
6.2. AstraZeneca group Co.
6.3. Boehringer Ingelheim International GmbH
6.4. Bristol Myers Squibb (BMS)
6.5. Eli Lilly and Co.
6.6. Merck & Co. Inc.
6.7. Novartis International AG
6.8. Pfizer Inc.
6.9. Sanofi S.A.
6.10. Takeda Pharmaceuticals Co. Ltd
1. GLOBAL PEDIATRIC MEDICINES MARKET RESEARCH AND ANALYSIS BY DRUG TYPE, 2021-2028 ($ MILLION)
2. GLOBAL ALLERGY AND RESPIRATORY PEDIATRIC MEDICINES MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
3. GLOBAL CANCER THERAPY PEDIATRIC MEDICINES MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
4. GLOBAL CARDIOVASCULAR PEDIATRIC MEDICINES MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
5. GLOBAL GASTROINTESTINAL PEDIATRIC MEDICINES MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
6. GLOBAL PEDIATRIC MEDICINES MARKET RESEARCH AND ANALYSIS BY ROUTE OF ADMINISTRATION, 2021-2028 ($ MILLION)
7. GLOBAL ORAL PEDIATRIC MEDICINES MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
8. GLOBAL TOPICAL PEDIATRIC MEDICINES MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
9. GLOBAL PARENTERAL PEDIATRIC MEDICINES MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
10. GLOBAL PEDIATRIC MEDICINES MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2021-2028 ($ MILLION)
11. NORTH AMERICAN PEDIATRIC MEDICINES MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
12. NORTH AMERICAN PEDIATRIC MEDICINES MARKET RESEARCH AND ANALYSIS BY DRUG TYPE, 2021-2028 ($ MILLION)
13. NORTH AMERICAN PEDIATRIC MEDICINES MARKET RESEARCH AND ANALYSIS BY ROUTE OF ADMINISTRATION FORM, 2021-2028 ($ MILLION)
14. EUROPEAN PEDIATRIC MEDICINES MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
15. EUROPEAN PEDIATRIC MEDICINES MARKET RESEARCH AND ANALYSIS BY DRUG TYPE, 2021-2028 ($ MILLION)
16. EUROPEAN PEDIATRIC MEDICINES MARKET RESEARCH AND ANALYSIS BY ROUTE OF ADMINISTRATION FORM, 2021-2028 ($ MILLION)
17. ASIA-PACIFIC PEDIATRIC MEDICINES MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
18. ASIA-PACIFIC PEDIATRIC MEDICINES MARKET RESEARCH AND ANALYSIS BY DRUG TYPE, 2021-2028 ($ MILLION)
19. ASIA-PACIFIC PEDIATRIC MEDICINES MARKET RESEARCH AND ANALYSIS BY ROUTE OF ADMINISTRATION FORM, 2021-2028 ($ MILLION)
20. REST OF THE WORLD PEDIATRIC MEDICINES MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
21. REST OF THE WORLD PEDIATRIC MEDICINES MARKET RESEARCH AND ANALYSIS BY DRUG TYPE, 2021-2028 ($ MILLION)
22. REST OF THE WORLD PEDIATRIC MEDICINES MARKET RESEARCH AND ANALYSIS BY ROUTE OF ADMINISTRATION FORM, 2021-2028 ($ MILLION)
FIGURES
1. IMPACT OF COVID-19 ON GLOBAL PEDIATRIC MEDICINES MARKET, 2021-2028 ($ MILLION)
2. IMPACT OF COVID-19 ON GLOBAL PEDIATRIC MEDICINES MARKET BY SEGMENT, 2021-2028 ($ MILLION)
3. RECOVERY OF GLOBAL PEDIATRIC MEDICINES MARKET, 2021-2028 (%)
4. GLOBAL PEDIATRIC MEDICINES MARKET SHARE BY DRUG TYPE, 2021 VS 2028 (%)
5. GLOBAL ALLERGY AND RESPIRATORY PEDIATRIC MEDICINES MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
6. GLOBAL CANCER THERAPY PEDIATRIC MEDICINES MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
7. GLOBAL CARDIOVASCULAR PEDIATRIC MEDICINES MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
8. GLOBAL GASTROINTESTINAL PEDIATRIC MEDICINES MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
9.
10. GLOBAL PEDIATRIC MEDICINES MARKET SHARE BY ROUTE OF ADMINISTRATION FORM, 2021 VS 2028 (%)
11. GLOBAL ORAL PEDIATRIC MEDICINES MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
12. GLOBAL TOPICAL PEDIATRIC MEDICINES TABLETS MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
13. GLOBAL PARENTERAL PEDIATRIC MEDICINES MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
14. GLOBAL PEDIATRIC MEDICINES MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
15. US PEDIATRIC MEDICINES MARKET SIZE, 2021-2028 ($ MILLION)
16. CANADA PEDIATRIC MEDICINES MARKET SIZE, 2021-2028 ($ MILLION)
17. UK PEDIATRIC MEDICINES MARKET SIZE, 2021-2028 ($ MILLION)
18. FRANCE PEDIATRIC MEDICINES MARKET SIZE, 2021-2028 ($ MILLION)
19. GERMANY PEDIATRIC MEDICINES MARKET SIZE, 2021-2028 ($ MILLION)
20. ITALY PEDIATRIC MEDICINES MARKET SIZE, 2021-2028 ($ MILLION)
21. SPAIN PEDIATRIC MEDICINES MARKET SIZE, 2021-2028 ($ MILLION)
22. REST OF EUROPE PEDIATRIC MEDICINES MARKET SIZE, 2021-2028 ($ MILLION)
23. INDIA PEDIATRIC MEDICINES MARKET SIZE, 2021-2028 ($ MILLION)
24. CHINA PEDIATRIC MEDICINES MARKET SIZE, 2021-2028 ($ MILLION)
25. JAPAN PEDIATRIC MEDICINES MARKET SIZE, 2021-2028 ($ MILLION)
26. SOUTH KOREA PEDIATRIC MEDICINES MARKET SIZE, 2021-2028 ($ MILLION)
27. REST OF ASIA-PACIFIC PEDIATRIC MEDICINES MARKET SIZE, 2021-2028 ($ MILLION)
28. REST OF THE WORLD PEDIATRIC MEDICINES MARKET SIZE, 2021-2028 ($ MILLION)
